Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 11/20 | 0.49 |
| ▸ | CA1 | P00915 | 11/20 | 0.49 |
| ▸ | CA2 | P00918 | 11/20 | 0.49 |
| ▸ | CA9 | Q16790 | 7/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.42 |
| ▸ | FYN | P06241 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 4/20 | 0.37 |
| ▸ | CA5A | P35218 | 4/20 | 0.37 |
| ▸ | CA7 | P43166 | 4/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14339480 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL12083315 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL19954491 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL5018117 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL23483196 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL24149168 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL24996814 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL23484227 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL23743617 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 | |
| SCHEMBL25785684 | 1.00 | CA12 (0.49) | CA12CA1CA2CA9CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622498-B2 | Sugar derivatives comprising oxiranes or α, β-unsaturated δ-lactones, process for their preparation and their utilisation as pesticides | Instituto Politecnico de Santarem/Escoal Superior Agraria (PT) | 2009-11-24 | — | — | US | disclosed |
| US-7538139-B2 | Sugar derivatives comprising oxiranes or α, β-unsaturated γ-lactones, process for their preparation and their utilisation as pesticides | Instituto Politecnico De Santarem/Escola Superior Agraria (PT) | 2009-05-26 | — | — | US | disclosed |
| US-20080004339-A1 | Sugar derivatives comprising oxiranes or alpha, beta-unsaturated delta-lactones, process for their preparation and their utilisation as pesticides | Instituto Politecnico De Santarem/Escola Superior Agraria (PT) | 2008-01-03 | — | — | US | disclosed |
| US-20070117865-A1 | Sugar derivatives comprising oxiranes or alpha, beta-unsaturated gamma-lactones, process for their preparation and their utilisation as pesticides | Instituto Politecnico De Santarem/Escola Superior Agraria (PT) | 2007-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070117865-A1 | Sugar derivatives comprising oxiranes or alpha, beta-unsaturated gamma-lactones, process for their preparation and their utilisation as pesticides | OXER1, OXSR1, CBR1 | CA12 1564/4885CA1 630/4885CA2 1159/4885 |
| US-20080004339-A1 | Sugar derivatives comprising oxiranes or alpha, beta-unsaturated delta-lactones, process for their preparation and their utilisation as pesticides | OXER1, CBR1, OXSR1 | CA12 1526/4885CA1 570/4885CA2 760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.